Applying 'omics technologies in chemicals risk assessment: Report of an ECETOC workshop
File(s)1-s2.0-S027323001730274X-main.pdf (570.34 KB)
Published version
Author(s)
Type
Journal Article
Abstract
Prevailing knowledge gaps in linking specific molecular changes to apical outcomes and methodological uncertainties in the generation, storage, processing, and interpretation of 'omics data limit the application of 'omics technologies in regulatory toxicology. Against this background, the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) convened a workshop Applying 'omics technologies in chemicals risk assessment that is reported herein. Ahead of the workshop, multi-expert teams drafted frameworks on best practices for (i) a Good-Laboratory Practice-like context for collecting, storing and curating 'omics data; (ii) the processing of 'omics data; and (iii) weight-of-evidence approaches for integrating 'omics data. The workshop participants confirmed the relevance of these Frameworks to facilitate the regulatory applicability and use of 'omics data, and the workshop discussions provided input for their further elaboration. Additionally, the key objective (iv) to establish approaches to connect 'omics perturbations to phenotypic alterations was addressed. Generally, it was considered promising to strive to link gene expression changes and pathway perturbations to the phenotype by mapping them to specific adverse outcome pathways. While further work is necessary before gene expression changes can be used to establish safe levels of substance exposure, the ECETOC workshop provided important incentives towards achieving this goal.
Date Issued
2017-09-25
Date Acceptance
2017-09-02
Citation
Regulatory Toxicology and Pharmacology, 2017, 91, pp.S3-S13
ISSN
0273-2300
Publisher
Elsevier
Start Page
S3
End Page
S13
Journal / Book Title
Regulatory Toxicology and Pharmacology
Volume
91
Copyright Statement
Crown Copyright © 2017 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
4.0/).
Subjects
Science & Technology
Life Sciences & Biomedicine
Medicine, Legal
Pharmacology & Pharmacy
Toxicology
Legal Medicine
Regulatory toxicology
Transcriptomics
Metabolomics
Good laboratory practice (GLP)
Weight-of-evidence (WoE)
Adverse outcome pathway (ADP)
Mode-of-action (MoA)
Gene expression
Differentially expressed genes
ADVERSE OUTCOME PATHWAYS
REGULATORY TOXICOLOGY
CONCEPTUAL-FRAMEWORK
KEY EVENTS
TOXICOGENOMICS
PERSPECTIVES
CONCORDANCE
CARCINOGENS
DEPARTURE
EXPOSURE
Publication Status
Published